The epigenetics of frailty

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Angioni D, Lu WH, Sourdet S et al. MAPT/DSA Group. Biomarkers of age-related frailty and frailty related to diseases: an exploratory, cross-sectional analysis from the MAPT study. J. Nutr. Health Aging 26, 545–551 (2022).
  Medline CASGoogle Scholar
• 2. Kennedy BK, Berger SL, Brunet A et al. Geroscience: linking aging to chronic disease. Cell 159, 709–713 (2014).
  Medline CASGoogle Scholar
• 3. Panza F, Lozupone M, Solfrizzi V et al. Different cognitive frailty models and health-and cognitive-related outcomes in older age: from epidemiology to prevention. J. Alz. Dis. 62(3), 993–1012 (2018).
  MedlineGoogle Scholar
• 4. Panza F, Solfrizzi V, Sardone R et al. Depressive and biopsychosocial frailty phenotypes: impact on late-life cognitive disorders. J. Alz. Dis. 94(3), 879–898 (2023). • Current evidence on the existing links between depressive and biopsychosocial frailty phenotypes and late-life cognitive disorders, with discussion of the common pathways and mechanisms underlying these links.
  MedlineGoogle Scholar
• 5. Fried LP, Tangen CM, Walston J et al. Frailty in older adults: evidence for a phenotype. J. Gerontol. A Biol. Sci. Med. Sci. 56(3), 146–156 (2001). •• Seminal study that provides a potential standardized definition for frailty in community-dwelling older adults and offers concurrent and predictive validity for the definition.
  Medline CASGoogle Scholar
• 6. Castellana F, Lampignano L, Bortone I et al. Physical frailty, multimorbidity, and all-cause mortality in an older population from southern Italy: results from the Salus in Apulia study. J. Am. Med. Dir. Assoc. 22(3), 598–605 (2021).
  MedlineGoogle Scholar
• 7. Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. Sci. World J. 1, 323–336 (2001).
  CASGoogle Scholar
• 8. Zupo R, Castellana F, Bortone I et al. Nutritional domains in frailty tools: working towards an operational definition of nutritional frailty. Ageing Res. Rev. 64, 101148 (2020).
  MedlineGoogle Scholar
• 9. Dibello V, Zupo R, Sardone R et al. Oral frailty and its determinants in older age: a systematic review. Lancet Healthy Longev. 2(8), e507–e520 (2021).
  MedlineGoogle Scholar
• 10. Ruan Q, Xiao F, Gong K et al. Prevalence of cognitive frailty phenotypes and associated factors in a community-dwelling elderly population. J. Nutr. Health Aging 24(2), 172–180 (2020).
  Medline CASGoogle Scholar
• 11. Zupo R, Castellana F, Donghia R et al. Liver frailty and all-cause mortality in the older participants of the Salus in Apulia study. Geroscience 44(2), 835–845 (2022).
  MedlineGoogle Scholar
• 12. Tsutsumimoto K, Doi T, Makizako H et al. Association of social frailty with both cognitive and physical deficits among older people. J. Am. Med. Dir. Assoc. 18(7), 603–607 (2017).
  MedlineGoogle Scholar
• 13. Solfrizzi V, Scafato E, Lozupone M et al. Biopsychosocial frailty and the risk of incident dementia: the Italian longitudinal study on aging. Alzheimers Dement. 15(8), 1019–1028 (2019).
  MedlineGoogle Scholar
• 14. Panza F, Solfrizzi V, Lozupone M et al. An old challenge with new promises: a systematic review on comprehensive geriatric assessment in long-term care facilities. Rejuvenation Res. 21(1), 3–14 (2018).
  MedlineGoogle Scholar
• 15. Ferrucci L, Levine ME, Kuo PL, Simonsick EM. Time and the metrics of aging. Circ. Res. 123(7), 740–744 (2018).
  Medline CASGoogle Scholar
• 16. Lopez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell 153, 1194–1217 (2013). •• Review article that enumerates nine tentative hallmarks that represent common denominators of aging in different organisms, with special emphasis on mammalian aging.
  Medline CASGoogle Scholar
• 17. Shadyab AH, LaCroix AZ. Genetic factors associated with longevity: a review of recent findings. Ageing Res. Rev. 19, 1–7 (2015).
  Medline CASGoogle Scholar
• 18. Pilling LC, Kuo C-L, Sicinski K et al. Human longevity: 25 genetic loci associated in 389,166 UK Biobank participants. Aging 9, 2504 (2017).
  Medline CASGoogle Scholar
• 19. Atkins JL, Jylhävä J, Pedersen NL et al. A genome-wide association study of the frailty index highlights brain pathways in ageing. Aging Cell 20(9), e13459 (2021).
  Medline CASGoogle Scholar
• 20. Sathyan S, Verghese J. Genetics of frailty: a longevity perspective. Transl. Res. 221, 83–96 (2020).
  Medline CASGoogle Scholar
• 21. Pal S, Tyler JK. Epigenetics and aging. Sci. Adv. 4(2), e1600584 (2016).
  Google Scholar
• 22. Lozupone M, La Montagna M, D’Urso F et al. The role of biomarkers in psychiatry. Adv. Exp. Med. Biol. 1118, 135–162 (2019).
  Medline CASGoogle Scholar
• 23. Brunet A, Berger SL. Epigenetics of aging and aging-related disease. J. Gerontol. A Biol. Sci. Med. Sci. 69(Suppl. 1), S17–S20 (2014).
  MedlineGoogle Scholar
• 24. Munoz-Najar U, Sedivy JM. Epigenetic control of aging. Antioxid. Redox Signal. 14(2), 241–259 (2011).
  Medline CASGoogle Scholar
• 25. Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat. Rev. Genet. 19(6), 371–384 (2018). • Discusses how accelerated epigenetic age predicts several age-related phenotypes. The existing DNAm age and DNAm PhenoAge estimators have demonstrated that these epigenetic biomarkers of aging satisfy the properties of molecular biomarkers of aging.
  Medline CASGoogle Scholar
• 26. Schübeler D. Function and information content of DNA methylation. Nature 517(7534), 321–326 (2015).
  Medline CASGoogle Scholar
• 27. Teschendorff AE, Relton CL. Statistical and integrative system-level analysis of DNA methylation data. Nat. Rev. Genet. 19(3), 129–147 (2018).
  Medline CASGoogle Scholar
• 28. Collerton J, Gautrey HE, van Otterdijk SD et al. Acquisition of aberrant DNA methylation is associated with frailty in the very old: findings from the Newcastle 85+ study. Biogerontology 15(4), 317–328 (2014).
  Medline CASGoogle Scholar
• 29. Gao X, Zhang Y, Saum K-U, Schöttker B, Breitling LP, Brenner H. Tobacco smoking and smoking-related DNA methylation are associated with the development of frailty among older adults. Epigenetics 12(2), 149–156 (2017).
  MedlineGoogle Scholar
• 30. Breitling LP, Saum KU, Perna L, Schöttker B, Holleczek B, Brenner H. Frailty is associated with the epigenetic clock but not with telomere length in a German cohort. Clin. Epigenet. 8, 21 (2016).
  MedlineGoogle Scholar
• 31. Gale CR, Marioni RE, Harris SE, Starr JM, Deary IJ. DNA methylation and the epigenetic clock in relation to physical frailty in older people: the Lothian Birth Cohort 1936. Clin. Epigenet. 10(1), 101 (2018).
  MedlineGoogle Scholar
• 32. Ipson BR, Fletcher MB, Espinoza SE, Fisher AL. Identifying exosome-derived microRNAs as candidate biomarkers of frailty. J. Frailty Aging 7(2), 100–103 (2018).
  Medline CASGoogle Scholar
• 33. Rusanova I, Diaz-Casado ME, Fernández-Ortiz M et al. Analysis of plasma microRNAs as predictors and biomarkers of aging and frailty in humans. Oxid. Med. Cell. Longev. 2018, 7671850 (2018).
  MedlineGoogle Scholar
• 34. Vetter VM, Spira D, Banszerus VL, Demuth I. Epigenetic clock and leukocyte telomere length are associated with vitamin D status but not with functional assessments and frailty in the Berlin aging study II. J. Gerontol. A Biol. Sci. Med. Sci. 75(11), 2056–2063 (2020).
  Medline CASGoogle Scholar
• 35. Bacalini MG, Gentilini D, Monti D et al. No association between frailty index and epigenetic clocks in Italian semi-supercentenarians. Mech. Ageing Dev. 197, 111514 (2021).
  Medline CASGoogle Scholar
• 36. Carini G, Mingardi J, Bolzetta F et al. miRNome profiling detects miR-101-3p and miR-142-5p as putative blood biomarkers of frailty syndrome. Genes 13(2), 231 (2022). •• Study that identified two miRNAs (miR-101-3p and miR-142-5p) able to significantly differentiate frail patients (downregulated) from robust subjects.
  Medline CASGoogle Scholar
• 37. Bellizzi D, D’Aquila P, Montesanto A et al. Global DNA methylation in old subjects is correlated with frailty. Age 34(1), 169–179 (2012). • Study showing how modifications of DNA methylation, a drawbridge between the genetic and the environmental factors affecting the age-related decay of the organism, may play an important role in determining physiological changes of old age.
  Medline CASGoogle Scholar
• 38. Lin Q, Weidner CI, Costa IG et al. DNA methylation levels at individual age-associated CpG sites can be indicative for life expectancy. Aging 8(2), 394–401 (2016).
  Medline CASGoogle Scholar
• 39. Kim S, Myers L, Wyckoff J, Cherry KE, Jazwinski SM. The frailty index outperforms DNA methylation age and its derivatives as an indicator of biological age. Geroscience 39(1), 83–92 (2017).
  Medline CASGoogle Scholar
• 40. Zhang Y, Saum KU, Schöttker B, Holleczek B, Brenner H. Methylomic survival predictors, frailty, and mortality. Aging 10(3), 339–357 (2018).
  Medline CASGoogle Scholar
• 41. Li X, Ploner A, Wang Y et al. Longitudinal trajectories, correlations and mortality associations of nine biological ages across 20-years follow-up. Elife 9, e51507 (2020).
  Medline CASGoogle Scholar
• 42. McCrory C, Fiorito G, Hernandez B et al. GrimAge outperforms other epigenetic clocks in the prediction of age-related clinical phenotypes and all-cause mortality. J. Gerontol. A Biol. Sci. Med. Sci. 76(5), 741–749 (2021). • Study indicating that the GrimAge clock may represent a step-improvement in the predictive utility of epigenetic clocks for identifying age-related decline in an array of clinical phenotypes, promising to advance precision medicine.
  MedlineGoogle Scholar
• 43. Seligman BJ, Berry SD, Lipsitz LA, Travison TG, Kiel DP. Epigenetic age acceleration and change in frailty in MOBILIZE Boston. J. Gerontol. A Biol. Sci. Med. Sci. 77(9), 1760–1765 (2022). • Study showing that baseline frailty index was correlated with extrinsic, GrimAge and PhenoAge epigenetic age acceleration, but no epigenetic age acceleration measure was associated with change in frailty.
  Medline CASGoogle Scholar
• 44. Kuiper LM, Polinder-Bos HA, Bizzarri D et al. Epigenetic and metabolomic biomarkers for biological age: a comparative analysis of mortality and frailty risk. J. Gerontol. A Biol. Sci. Med. Sci. 78(10), 1753–1762 (2023).
  MedlineGoogle Scholar
• 45. Fraga MF. Genetic and epigenetic regulation of aging. Curr. Opin. Immunol. 21(4), 446–453 (2009).
  Medline CASGoogle Scholar
• 46. Kawakami K, Nakamura A, Ishigami A, Goto S, Takahashi R. Age-related difference of site-specific histone modifications in rat liver. Biogerontology 10(4), 415–421 (2009).
  Medline CASGoogle Scholar
• 47. Gravina S, Vijg J. Epigenetic factors in aging and longevity. Pflugers Arch. 459(2), 247–258 (2010).
  Medline CASGoogle Scholar
• 48. Rando TA. Epigenetics and aging. Exp. Gerontol. 45(4), 253–254 (2010).
  MedlineGoogle Scholar
• 49. Wilson VL, Smith RA, Ma S, Cutler RG. Genomic 5-methyldeoxycytidine decreases with age. J. Biol. Chem. 262(21), 9948–9951 (1987).
  Medline CASGoogle Scholar
• 50. Oakes CC, Smiraglia DJ, Plass C, Trasler JM, Robaire B. Aging results in hypermethylation of ribosomal DNA in sperm and liver of male rats. Proc. Natl Acad. Sci. USA 100(4), 1775–1780 (2003).
  Medline CASGoogle Scholar
• 51. Richardson B. Impact of aging on DNA methylation. Ageing Res. Rev. 2(3), 245–261 (2003).
  Medline CASGoogle Scholar
• 52. Ling C, Del Guerra S, Lupi R et al. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia 51(4), 615–622 (2008).
  Medline CASGoogle Scholar
• 53. Fraga MF, Esteller M. Epigenetics and aging: the targets and the marks. Trends Genet. 23(8), 413–418 (2007).
  Medline CASGoogle Scholar
• 54. Lee J, Jeong DJ, Kim J et al. The anti-aging gene KLOTHO is a novel target for epigenetic silencing in human cervical carcinoma. Mol. Cancer 9, 109 (2010).
  MedlineGoogle Scholar
• 55. Arai T, Kasahara I, Sawabe M, Honma N, Aida J, Tabubo K. Role of methylation of the hMLH1 gene promoter in the development of gastric and colorectal carcinoma in the elderly. Geriatr. Gerontol. Int. 10(Suppl. 1), S207–S212 (2010).
  MedlineGoogle Scholar
• 56. Bell CG, Lowe R, Adams PD et al. DNA methylation aging clocks: challenges and recommendations. Genome Biol. 20(1), 249 (2019).
  MedlineGoogle Scholar
• 57. Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 14(10), R115 (2013).
  MedlineGoogle Scholar
• 58. Oblak L, van der Zaag J, Higgins-Chen AT, Levine ME, Boks MP. A systematic review of biological, social and environmental factors associated with epigenetic clock acceleration. Ageing Res. Rev. 69, 101348 (2021).
  Medline CASGoogle Scholar
• 59. Levine ME, Higgins-Chen A, Thrush K, Minteer C, Niimi P. Clock work: deconstructing the epigenetic clock signals in aging, disease, and reprogramming. bioRxiv doi: 10.1101/2022.02.13.480245 (2022) (Preprint).
  Google Scholar
• 60. Hannum G, Guinney J, Zhao L et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol. Cell 49(2), 359–367 (2013).
  Medline CASGoogle Scholar
• 61. Evert J, Lawler E, Bogan H, Perls T. Morbidity profiles of centenarians: survivors, delayers, and escapers. J. Gerontol. A Biol. Sci. Med. Sci. 58(3), 232–237 (2003).
  MedlineGoogle Scholar
• 62. Marzetti E, Lorenzi M, Antocicco M et al. Shorter telomeres in peripheral blood mononuclear cells from older persons with sarcopenia: results from an exploratory study. Front. Aging Neurosci. 6, 233 (2014).
  MedlineGoogle Scholar
• 63. Jilhava J, Pedersen NL, Hägg S. Biological age predictors. EBioMedicine 21, 29–36 (2017).
  MedlineGoogle Scholar
• 64. Fasanelli F, Baglietto L, Ponzi E et al. Hypomethylation of smoking-related genes is associated with future lung cancer in four prospective cohorts. Nat. Commun. 6, 10192 (2015).
  Medline CASGoogle Scholar
• 65. Zhang Y, Schöttker B, Florath I et al. Smoking-associated DNA methylation biomarkers and their predictive value for all-cause and cardiovascular mortality. Environ. Health Perspect. 124(1), 67–74 (2016).
  Medline CASGoogle Scholar
• 66. Zhong J, He Y, Chen W, Shui X, Chen C, Lei W. Circulating microRNA-19a as a potential novel biomarker for diagnosis of acute myocardial infarction. Int. J. Mol. Sci. 15(11), 20355–20364 (2014).
  Medline CASGoogle Scholar
• 67. Bernabeu E, McCartney DL, Gadd DA et al. Refining epigenetic prediction of chronological and biological age. Genome Med. 15(1), 12 (2023).
  Medline CASGoogle Scholar
• 68. Belsky DW, Caspi A, Corcoran DL et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. Elife 11, e73420 (2022).
  Medline CASGoogle Scholar
• 69. Lu AT, Binder AM, Zhang J et al. DNA methylation GrimAge version 2. Aging 14(23), 9484–9549 (2022).
  Medline CASGoogle Scholar
• 70. Maddock J, Castillo-Fernandez J, Wong A et al. DNA methylation age and physical and cognitive aging. J. Gerontol. A Biol. Sci. Med. Sci. 75(3), 504–511 (2020).
  Medline CASGoogle Scholar
• 71. Verschoor CP, Lin DTS, Kobor MS et al. Epigenetic age is associated with baseline and 3-year change in frailty in the Canadian Longitudinal Study on Aging. Clin. Epigenetics 13(1), 163 (2021).
  Medline CASGoogle Scholar
• 72. Levine ME, Lu AT, Quach A et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging 10(4), 573–591 (2018).
  MedlineGoogle Scholar
• 73. Lu AT, Quach A, Wilson JG et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging 11(2), 303–327 (2019).
  Medline CASGoogle Scholar
• 74. Gobbens RJJ, Boersma P, Uchmanowicz I, Santiago LM. The Tilburg frailty indicator (TFI): new evidence for its validity. Clin. Interv. Aging 15, 265–274 (2020).
  MedlineGoogle Scholar
• 75. Wu C, Geldhof GJ, Xue QL, Kim DH, Newman AB, Odden MC. Development, construct validity, and predictive validity of a continuous frailty scale: results from 2 large US cohorts. Am. J. Epidemiol. 187(8), 1752–1762 (2018).
  MedlineGoogle Scholar
• 76. Pilotto A, Ferrucci L, Franceschi M et al. Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients. Rejuvenation Res. 11(1), 151–161 (2008).
  MedlineGoogle Scholar
• 77. Solfrizzi V, Scafato E, Lozupone M et al. Italian Longitudinal Study on Aging Working Group. Additive role of a potentially reversible cognitive frailty model and inflammatory state on the risk of disability: the Italian Longitudinal Study on Aging. Am. J. Geriatr. Psychiatry 25(11), 1236–1248 (2017).
  MedlineGoogle Scholar
• 78. Ambros V. The functions of animal microRNAs. Nature 431(7006), 350–355 (2004).
  Medline CASGoogle Scholar
• 79. Lu TX, Rothenberg ME. MicroRNA. J. Allergy Clin. Immunol. 141(4), 1202–1207 (2018).
  Medline CASGoogle Scholar
• 80. Rusanova I, Fernández-Martínez J, Fernández-Ortiz M et al. Involvement of plasma miRNAs, muscle miRNAs and mitochondrial miRNAs in the pathophysiology of frailty. Exp. Gerontol. 124, 110637 (2019).
  Medline CASGoogle Scholar
• 81. Pan Y, Ji T, Li Y, Ma L. Omics biomarkers for frailty in older adults. Clin. Chim. Acta 510, 363–372 (2020).
  Medline CASGoogle Scholar
• 82. Xue QL. The frailty syndrome: definition and natural history. Clin. Geriatr. Med. 27(1), 1–15 (2011).
  Medline CASGoogle Scholar
• 83. Cruz-Jentoft AJ, Bahat G, Bauer J et al. Sarcopenia: revised European consensus on definition and diagnosis. Age. Ageing 48(4), 601 (2019).
  MedlineGoogle Scholar
• 84. Olivieri F, Rippo MR, Procopio AD, Fazioli F. Circulating inflamma-miRs in aging and age-related diseases. Front. Genet. 4, 121 (2013).
  Medline CASGoogle Scholar
• 85. Suh N. MicroRNA controls of cellular senescence. BMB Rep. 51(10), 493–499 (2018).
  Medline CASGoogle Scholar
• 86. Yin J, Qian Z, Chen Y, Li Y, Zhou X. MicroRNA regulatory networks in the pathogenesis of sarcopenia. J. Cell. Mol. Med. 24(9), 4900–4912 (2020).
  Medline CASGoogle Scholar
• 87. Sarkar SN, Russell AE, Engler-Chiurazzi EB, Porter KN, Simpkins JW. MicroRNAs and the genetic nexus of brain aging, neuroinflammation, neurodegeneration, and brain trauma. Aging Dis. 10(2), 329–352 (2019).
  MedlineGoogle Scholar
• 88. Mone P, de Donato A, Varzideh F et al. Functional role of miR-34a in diabetes and frailty. Front. Aging 3, 949924 (2022).
  MedlineGoogle Scholar
• 89. Zheng Y, Kong J, Li Q, Wang Y, Li J. Role of miRNAs in skeletal muscle aging. Clin. Interv. Aging 13, 2407–2419 (2018).
  Medline CASGoogle Scholar
• 90. Fabbri M, Paone A, Calore F, Galli R, Croce CM. A new role for microRNAs, as ligands of Toll-like receptors. RNA Biol. 10(2), 169–174 (2013).
  Medline CASGoogle Scholar
• 91. Xu T, Zhou Q, Che L et al. Circulating miR-21, miR-378, and miR-940 increase in response to an acute exhaustive exercise in chronic heart failure patients. Oncotarget 7(11), 12414–12425 (2016).
  MedlineGoogle Scholar
• 92. Boyd-Kirkup JD, Green CD, Wu G, Wang D, Han JD. Epigenomics and the regulation of aging. Epigenomics 5(2), 205–227 (2013).
  CASGoogle Scholar
• 93. Wagner K-H, Cameron-Smith D, Wessner B, Franzke B. Biomarkers of aging: from function to molecular biology. Nutrients 8(6), 338 (2016).
  MedlineGoogle Scholar
• 94. Nascimento CM, Ingles M, Salvador-Pascual A, Cominetti MR, Gomez-Cabrera MC, Viña J. Sarcopenia, frailty and their prevention by exercise. Free Radic. Biol. Med. 132, 42–49 (2019).
  Medline CASGoogle Scholar
• 95. Viña J, Tarazona-Santabalbina FJ, Pérez-Ros P et al. Biology of frailty: modulation of ageing genes and its importance to prevent age-associated loss of function. Mol. Asp. Med. 50, 88–108 (2016).
  MedlineGoogle Scholar
• 96. Drummond MJ, McCarthy JJ, Sinha M et al. Aging and microRNA expression in human skeletal muscle: a microarray and bioinformatics analysis. Physiol. Genomics 43(10), 595–603 (2011).
  Medline CASGoogle Scholar
• 97. Margolis LM, McClung HL, Murphy NE, Carrigan CT, Pasiakos SM. Skeletal muscle myomiR are differentially expressed by endurance exercise mode and combined essential amino acid and carbohydrate supplementation. Front. Physiol. 8, 182 (2017).
  MedlineGoogle Scholar
• 98. Russell AP, Lamon S, Boon H et al. Regulation of miRNAs in human skeletal muscle following acute endurance exercise and short-term endurance training. J. Physiol. 591(18), 4637–4653 (2013).
  Medline CASGoogle Scholar
• 99. Nielsen S, Åkerström T, Rinnov A et al. The miRNA plasma signature in response to acute aerobic exercise and endurance training. PLOS ONE 9(2), e87308 (2014).
  MedlineGoogle Scholar
• 100. Agostini S, Mancuso R, Costa AS et al. Sarcopenia associates with SNAP-25 SNPs and a miRNAs profile which is modulated by structured rehabilitation treatment. J. Transl. Med. 19(1), 315 (2021).
  Medline CASGoogle Scholar
• 101. Agostini S, Mancuso R, Citterio LA, Mihali GA, Arosio B, Clerici M. Evaluation of serum miRNAs expression in frail and robust subjects undergoing multicomponent exercise protocol (VIVIFRAIL). J. Transl. Med. 21(1), 67 (2023). • The findings suggest that serum miRNA-451a should be investigated as a potential biomarker for frailty and that a multicomponent program of physical exercise modulates circulatory miRNA expression.
  Medline CASGoogle Scholar
• 102. Bacalini MG, Friso S, Olivieri F et al. Present and future of anti-ageing epigenetic diets. Mech. Ageing Dev. 136–137, 101–115 (2014).
  Medline CASGoogle Scholar
• 103. Kok DEG, Dhonukshe-Rutten RAM, Lute C et al. The effects of long-term daily folic acid and vitamin B12 supplementation on genome-wide DNA methylation in elderly subjects. Clin. Epigenetics 7, 121 (2015).
  MedlineGoogle Scholar
• 104. Quach A, Levine ME, Tanaka T et al. Epigenetic clock analysis of diet, exercise, education, and lifestyle factors. Aging 9(2), 419–446 (2017).
  Medline CASGoogle Scholar
• 105. Gensous N, Garagnani P, Santoro A et al. One-year Mediterranean diet promotes epigenetic rejuvenation with country- and sex-specific effects: a pilot study from the NU-AGE project. Geroscience 42(2), 687–701 (2020). •• The findings suggest that a Mediterranean diet can promote epigenetic rejuvenation but with country-, sex-, and individual-specific effects, thus highlighting the need for a personalized approach to nutritional interventions.
  MedlineGoogle Scholar
• 106. Teo N, Yeo PS, Gao Q et al. A bio-psycho-social approach for frailty amongst Singaporean Chinese community-dwelling older adults – evidence from the Singapore Longitudinal Aging Study. BMC Geriatr. 19(1), 50 (2019).
  MedlineGoogle Scholar
• 107. Lozupone M, Panza F. Social determinants of late life depression epigenetics. Epigenomics 12(7), 559–562 (2020).
  CASGoogle Scholar
• 108. Araújo Carvalho AC, Tavares Mendes ML, da Silva Reis MC, Santos VS, Tanajura DM, Martins-Filho PRS. Telomere length and frailty in older adults – a systematic review and meta-analysis. Ageing Res. Rev. 54, 100914 (2019).
  MedlineGoogle Scholar
• 109. Gale CR, Cooper C. Attitudes to ageing and change in frailty status: the English longitudinal study of ageing. Gerontology 64(1), 58–66 (2017). • Older people who have a more positive attitude to ageing are at reduced risk of becoming physically frail or pre-frail.
  MedlineGoogle Scholar
• 110. Morley JE, Vellas B, van Kan GA et al. Frailty consensus: a call to action. J. Am. Med. Dir. Assoc. 14(6), 392–397 (2013).
  MedlineGoogle Scholar
• 111. Seripa D, Solfrizzi V, Imbimbo BP et al. Tau-directed approaches for the treatment of Alzheimer’s disease: focus on leuco-methylthioninium. Expert Rev. Neurother. 16(3), 259–277 (2016).
  Medline CASGoogle Scholar
• 112. Lozupone M, Solfrizzi V, D'Urso F et al. Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs. Expert Opin. Emerg. Drugs 25(3), 319–335 (2020).
  Medline CASGoogle Scholar
• 113. Zupo R, Castellana F, Guerra V et al. Associations between nutritional frailty and 8-year all-cause mortality in older adults: the Salus in Apulia study. J. Intern. Med. 290(5), 1071–1082 (2021).
  MedlineGoogle Scholar
• 114. Lozupone M, D'Urso F, Piccininni C et al. The relationship between epigenetics and microbiota in neuropsychiatric diseases. Epigenomics 12(17), 1559–1568 (2020).
  CASGoogle Scholar